Curated News
By: NewsRamp Editorial Staff
August 31, 2026
PSMA Testing: A Vital Tool in Prostate Cancer Care
TLDR
- Early PSMA testing can reveal cancer spread, enabling timely treatment and improving outcomes, offering a strategic edge in prostate cancer management.
- PSMA testing uses a PET scan to detect a biomarker on prostate cancer cells, guiding treatment decisions based on the extent of disease spread.
- PSMA testing empowers patients like Bill to actively participate in their care, fostering informed decisions and a sense of control in their cancer journey.
- Did you know that 80-90% of prostate cancer patients express PSMA, making it a key target for both diagnosis and targeted therapies?
Impact - Why it Matters
Understanding PSMA testing can be a game-changer for men facing prostate cancer. This news matters because it provides clear, accessible information about a diagnostic tool that can significantly influence treatment decisions. By learning about PSMA and advocating for appropriate testing, patients can take a proactive role in their care, potentially leading to better outcomes. The collaboration between a medical expert and a patient advocate makes this information relatable and actionable, encouraging men to have informed discussions with their healthcare providers.
Summary
In a recent educational video, Dr. Phillip Koo, Executive Vice President and Chief Medical Officer at the Prostate Cancer Foundation, and Bill, a prostate cancer survivor and patient advocate, team up to demystify PSMA testing. Sponsored by Novartis, the discussion aims to empower men with knowledge about this crucial diagnostic tool. Dr. Koo highlights that prostate cancer affects roughly 1 in 8 men, emphasizing the importance of early screening through a simple PSA blood test. For those newly introduced to PSMA, he explains that it's a biomarker detectable via PET imaging, which helps determine if cancer has spread—a vital step in planning treatment. Notably, over 80-90% of prostate cancer patients express this biomarker, making PSMA testing highly relevant.
Bill shares his personal journey, having been diagnosed 18 years ago. He stresses the importance of taking an active role in one's healthcare, seeking information, and bringing options like PSMA testing to his doctor. After receiving his scan results, he felt empowered to craft a tailored treatment plan with his oncologist. Dr. Koo reinforces that patients should speak up and educate themselves to have informed conversations with their doctors. For more information, patients can visit GetYourScan.com, a resource provided by Novartis, to learn about PSMA scans and how to advocate for this important test in their care.
Source Statement
This curated news summary relied on content distributed by NewsUSA. Read the original source here, PSMA Testing: A Vital Tool in Prostate Cancer Care
